OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for November, 2016

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2016-11-30 12:15 In Lechleiter’s final days, Eli Lilly flags upcoming job cuts in the wake of a PhIII implosion and more... 2016-11-30 00:15 Grassley upset Mylan CEO to talk at industry event but won’t testify before Congress and more... 2016-11-29 12:15 Pharma-to-physician social media and app marketing will soar by 2018: report and more... 2016-11-29 00:15 With data in hand, GSK readies to expand Nucala label and more... 2016-11-28 12:15 FDA Grants Merck Priority Review for Keytruda Drug (MRK) and more... 2016-11-28 00:15 The FDA's Historic Caution On Abuse Deterrent Labeling and more... 2016-11-25 12:15 [video]J&amp;J Said to Make Takeover Approach for Actelion and more... 2016-11-24 00:15 Biogen loses $4 billion in market cap on Eli Lilly Azheimer's news 2016-11-23 12:15 Eli Lilly (LLY) CEO Lechleiter 'Disappointed,' after Alzheimer's Drug Fails and more... 2016-11-23 00:15 What Happened in Biotech in 2016? and more... 2016-11-22 12:15 Trial miss derails Acorda's Ampyra plans and more... 2016-11-22 00:15 $13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market and more... 2016-11-21 12:15 Brace Yourself: AstraZeneca Could Be a Fourth Entrant into the PD-1/PD-L1 Drug Class and more... 2016-11-21 00:15 5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them 2016-11-19 12:15 Drugmaker losses pull stocks lower; small-cap surge goes on and more... 2016-11-18 12:15 High-dollar Prescribers Proliferate in Medicare’s Drug Program and more... 2016-11-18 00:15 Chicago will license pharma sales reps to fight opioid overprescribing and more... 2016-11-17 12:15 Valeant tumbles after the CEO of its secret pharmacy was arrested and more... 2016-11-17 00:15 Former FDA official settles insider trading charges and more... 2016-11-16 12:15 Most doctors don’t cite cost as a factor when deciding treatments and more... 2016-11-15 12:15 Roche forms 21-site I/O R&amp;D network, commits $100M and more... 2016-11-15 00:15 Novartis mulls sale for underperforming Alcon eye division and more... 2016-11-14 12:15 Dynavax's stock plunges after disappointing FDA response to Hep-B treatment and more... 2016-11-14 00:15 J&amp;J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab 2016-11-13 12:15 Biotech insider Rich Bagger is out, Gingrich is up in latest reshuffle of Trump’s inner circle and more... 2016-11-13 00:15 Sanofi Took $100M Hit on MannKind Deal 2016-11-12 12:15 Key Factors In The Big Rally In Biotech and more... 2016-11-11 12:15 Keryx rebuilds supply for kidney drug and more... 2016-11-11 00:15 Gilead's hepatitis B drug gets U.S. approval and more... 2016-11-10 12:15 Pfizer wins EU's approval for Ibrance as Novartis readies rival drug and more... 2016-11-09 12:15 Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks? and more... 2016-11-09 00:15 Gilead Sciences: 5 Reasons to Buy Alexion…and 4 Reasons It Shouldn’t and more... 2016-11-08 12:15 Endo's profit, revenue top estimates on strong generic drug sales and more... 2016-11-08 00:15 World Leader in Diabetes Medication Hits 2-Year Low and more... 2016-11-07 12:15 Will drugmakers get what they're looking for at this week's FDA off-label hearing? and more... 2016-11-07 00:15 3 Best Biotech Stocks of the 21st Century (So Far) 2016-11-06 00:15 AbbVie Receives FDA Orphan Drug Designation for Investigational Medicine Veliparib for the Treatment of Advanced Squamous Non-Small Cell Lung Cancer and more... 2016-11-05 12:15 FDA panel narrowly backs Cempra antibiotic 2016-11-04 12:15 Bernie Sanders calls for federal investigation of insulin makers for price collusion and more... 2016-11-04 00:15 10 things for pharma marketers to know about Facebook and Instagram and more... 2016-11-03 12:15 More Valeant up for bid? Beseiged pharma weighs $2.5B sale of eye-surgery biz and more... 2016-11-03 00:15 What would a Salix sale do for Valeant? and more... 2016-11-02 12:15 Valeant in talks to sell Salix stomach-drug unit in $10 billion deal and more... 2016-11-02 00:15 Gilead Sciences shares slide after revenue beat, earnings miss and more... 2016-11-01 12:15 Pfizer Ends Trials for Cholesterol Drug as Earnings Fall Short and more... 2016-11-01 00:15 Valeant Plunges Anew On Report Of Possible Criminal Charges Against Former CEO, CFO and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe